Dataset Information

Dietary Polyphenol Intake is Associated with HDL-Cholesterol and A Better Profile of other Components of the Metabolic Syndrome: A PREDIMED-Plus Sub-Study.

ABSTRACT: Dietary polyphenol intake is associated with improvement of metabolic disturbances. The aims of the present study are to describe dietary polyphenol intake in a population with metabolic syndrome (MetS) and to examine the association between polyphenol intake and the components of MetS. This cross-sectional analysis involved 6633 men and women included in the PREDIMED (PREvención con DIeta MEDiterranea-Plus) study. The polyphenol content of foods was estimated from the Phenol-Explorer 3.6 database. The mean of total polyphenol intake was 846 ± 318 mg/day. Except for stilbenes, women had higher polyphenol intake than men. Total polyphenol intake was higher in older participants (>70 years of age) compared to their younger counterparts. Participants with body mass index (BMI) >35 kg/m² reported lower total polyphenol, flavonoid, and stilbene intake than those with lower BMI. Total polyphenol intake was not associated with a better profile concerning MetS components, except for high-density lipoprotein cholesterol (HDL-c), although stilbenes, lignans, and other polyphenols showed an inverse association with blood pressure, fasting plasma glucose, and triglycerides. A direct association with HDL-c was found for all subclasses except lignans and phenolic acids. To conclude, in participants with MetS, higher intake of several polyphenol subclasses was associated with a better profile of MetS components, especially HDL-c.

SUBMITTER: Castro-Barquero S

PROVIDER: S-EPMC7146338 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Dietary Polyphenol Intake is Associated with HDL-Cholesterol and A Better Profile of other Components of the Metabolic Syndrome: A PREDIMED-Plus Sub-Study.

Castro-Barquero Sara S Tresserra-Rimbau Anna A Vitelli-Storelli Facundo F Doménech Mónica M Salas-Salvadó Jordi J Martín-Sánchez Vicente V Rubín-García María M Buil-Cosiales Pilar P Corella Dolores D Fitó Montserrat M Romaguera Dora D Vioque Jesús J Alonso-Gómez Ángel María ÁM Wärnberg Julia J Martínez José Alfredo JA Serra-Majem Luís L Tinahones Francisco José FJ Lapetra José J Pintó Xavier X Tur Josep Antonio JA Garcia-Rios Antonio A García-Molina Laura L Delgado-Rodriguez Miguel M Matía-Martín Pilar P Daimiel Lidia L Vidal Josep J Vázquez Clotilde C Cofán Montserrat M Romanos-Nanclares Andrea A Becerra-Tomas Nerea N Barragan Rocio R Castañer Olga O Konieczna Jadwiga J González-Palacios Sandra S Sorto-Sánchez Carolina C Pérez-López Jessica J Zulet María Angeles MA Bautista-Castaño Inmaculada I Casas Rosa R Gómez-Perez Ana María AM Santos-Lozano José Manuel JM Rodríguez-Sanchez María Ángeles MÁ Julibert Alicia A Martín-Calvo Nerea N Hernández-Alonso Pablo P Sorlí José V JV Sanllorente Albert A Galmés-Panadés Aina María AM Cases-Pérez Eugenio E Goicolea-Güemez Leire L Ruiz-Canela Miguel M Babio Nancy N Hernáez Álvaro Á Lamuela-Raventós Rosa María RM Estruch Ramon R

Nutrients 20200304 3

Dietary polyphenol intake is associated with improvement of metabolic disturbances. The aims of the present study are to describe dietary polyphenol intake in a population with metabolic syndrome (MetS) and to examine the association between polyphenol intake and the components of MetS. This cross-sectional analysis involved 6633 men and women included in the PREDIMED (PREvención con DIeta MEDiterranea-Plus) study. The polyphenol content of foods was estimated from the Phenol-Explorer 3.6 databa ...[more]

PMID: 32143308

Similar Datasets

Project description:BackgroundPolyphenols may lower the risk of cardiovascular disease (CVD) and other chronic diseases due to their antioxidant and anti-inflammatory properties, as well as their beneficial effects on blood pressure, lipids and insulin resistance. However, no previous epidemiological studies have evaluated the relationship between the intake of total polyphenols intake and polyphenol subclasses with overall mortality. Our aim was to evaluate whether polyphenol intake is associated with all-cause mortality in subjects at high cardiovascular risk.MethodsWe used data from the PREDIMED study, a 7,447-participant, parallel-group, randomized, multicenter, controlled five-year feeding trial aimed at assessing the effects of the Mediterranean Diet in primary prevention of cardiovascular disease. Polyphenol intake was calculated by matching food consumption data from repeated food frequency questionnaires (FFQ) with the Phenol-Explorer database on the polyphenol content of each reported food. Hazard ratios (HR) and 95% confidence intervals (CI) between polyphenol intake and mortality were estimated using time-dependent Cox proportional hazard models.ResultsOver an average of 4.8 years of follow-up, we observed 327 deaths. After multivariate adjustment, we found a 37% relative reduction in all-cause mortality comparing the highest versus the lowest quintiles of total polyphenol intake (hazard ratio (HR) = 0.63; 95% CI 0.41 to 0.97; P for trend = 0.12). Among the polyphenol subclasses, stilbenes and lignans were significantly associated with reduced all-cause mortality (HR =0.48; 95% CI 0.25 to 0.91; P for trend = 0.04 and HR = 0.60; 95% CI 0.37 to 0.97; P for trend = 0.03, respectively), with no significant associations apparent in the rest (flavonoids or phenolic acids).ConclusionsAmong high-risk subjects, those who reported a high polyphenol intake, especially of stilbenes and lignans, showed a reduced risk of overall mortality compared to those with lower intakes. These results may be useful to determine optimal polyphenol intake or specific food sources of polyphenols that may reduce the risk of all-cause mortality.Clinical trial registrationISRCTN35739639.

Dataset Information

Dietary Polyphenol Intake is Associated with HDL-Cholesterol and A Better Profile of other Components of the Metabolic Syndrome: A PREDIMED-Plus Sub-Study.

Publications

Dietary Polyphenol Intake is Associated with HDL-Cholesterol and A Better Profile of other Components of the Metabolic Syndrome: A PREDIMED-Plus Sub-Study.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure